Gan and Lee Pharmaceuticals, USA

Related records

Trials (29)

• A Clinical Study of GZR33 and GZR101 in Healthy Subjects
• A Phase I Clinical Study to Evaluate the Effect of GZR18 Injection on the Pharmacokinetics of Oral Metformin Hydrochloride Tablets in Overweight/Obese Subjects
• A Phase I Study of GZR18 Injection in Healthy Subjects
• A Phase I Study of GZR18 Injection in Obese/Overweight Subjects
• A Study of GZR18 Injection in Chinese Adult Patients With Type 2 Diabetes Mellitus (T2DM)
• A Study of GZR18 Injection in Chinese Obese/Overweight Patients
• A Study of GZR18 Injection in Chinese Patients With Type 2 Diabetes Mellitus
• A Study of GZR18 Injection in Obese/Overweight Patients
• A Study of GZR18 Tablet in Chinese Healthy Subjects
• A Study of GZR4 Injection at Different Injection Sites
• A Study to Evaluate the Safety, Tolerance, PK and PD Parameters of GZR33 and GZR101 in Healthy Male Adult Subjects
• A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with T2DM
• A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD) and GZR33-70 Injection OD
• A Trial Comparing the Efficacy and Safety of GZR4 Injection Versus Insulin Degludec in Subjects with Type 2 Diabetes Mellitus
• A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GZR4 in Subjects With Type 2 Diabetes
• Clamp Study to Estimate the Relative Potency of GZR33 Versus Insulin Degludec at Steady State
• Comparison Study of Insulin GZR4 With Insulin Degludec
• Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants
• Evaluation of GLR2007 for Advanced Solid Tumors
• Gan & Lee Evaluation of New Biosimilar for Type 1 Lispro